{"transactions":[{"id":731905,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2026-06-18T21:17:32.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":90316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":90316,"derivative":{"underlying":"Common Stock","underlying_shares":90316},"source":{"system":"sec-edgar","filing":"0001104659-26-075863","document":"tm2618145-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926075863/tm2618145-5_4seq1.xml","form_type":"4"}},{"id":1107834,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2025-06-17T20:07:54.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":67546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":67546,"derivative":{"underlying":"Common Stock","underlying_shares":67546},"source":{"system":"sec-edgar","filing":"0001104659-25-060251","document":"tm2518181-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465925060251/tm2518181-3_4seq1.xml","form_type":"4"}},{"id":1480466,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2024-06-13T22:01:42.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":49303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":49303,"derivative":{"underlying":"Common Stock","underlying_shares":49303},"source":{"system":"sec-edgar","filing":"0001104659-24-071372","document":"tm2417165-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465924071372/tm2417165-3_4seq1.xml","form_type":"4"}},{"id":1595399,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2024-03-05T22:54:47.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant.  Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant.  Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":100000,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-24-031111","document":"tm248017-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465924031111/tm248017-7_4seq1.xml","form_type":"4"}},{"id":1862114,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2023-06-08T22:21:12.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":51955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":51955,"derivative":{"underlying":"Common Stock","underlying_shares":51955},"source":{"system":"sec-edgar","filing":"0001104659-23-069506","document":"tm2318216-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465923069506/tm2318216-3_4seq1.xml","form_type":"4"}},{"id":2232528,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2022-06-14T21:02:16.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":51204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting.  Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting.  Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":51204,"derivative":{"underlying":"Common Stock","underlying_shares":51204},"source":{"system":"sec-edgar","filing":"0001104659-22-071053","document":"tm2218366-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465922071053/tm2218366-4_4seq1.xml","form_type":"4"}},{"id":2247344,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T00:01:53.000Z","date":"2022-05-31","kind":"purchase","acquired":true,"shares":7813,"price":6.8,"value":53128.4,"ownership":{"direct":true},"balance_after":112632,"source":{"system":"sec-edgar","filing":"0001104659-22-067761","document":"tm2217576d3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465922067761/tm2217576d3_4seq1.xml","form_type":"4"}},{"id":2247343,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T00:01:53.000Z","date":"2022-05-31","kind":"purchase","acquired":true,"shares":2187,"price":6.79,"value":14849.73,"ownership":{"direct":true},"balance_after":104819,"source":{"system":"sec-edgar","filing":"0001104659-22-067761","document":"tm2217576d3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465922067761/tm2217576d3_4seq1.xml","form_type":"4"}},{"id":2647486,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-01T20:21:02.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are exercisable in four equal quarterly installments of 8,750 each following the date of grant, such that the options will be fully vested and exercisable on June 29, 2022."}],"balance_after":35000,"derivative":{"exercise_price":26.33,"expiration_date":"2031-06-29","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-21-088253","document":"tm2121236-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465921088253/tm2121236-5_4seq1.xml","form_type":"4"}},{"id":3114622,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-11T00:00:54.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are exercisable in four equal quarterly installments of 8,750 each following the date of grant, such that the options will be fully vested and exercisable on June 8, 2021."}],"balance_after":35000,"derivative":{"exercise_price":32.17,"expiration_date":"2030-06-07","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-20-072139","document":"tm2022303d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465920072139/tm2022303d3_4.xml","form_type":"4"}},{"id":3494035,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-11T21:16:15.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are exercisable in four equal quarterly installments of 12,500 each following the date of grant. If the Reporting Person's service to the Issuer terminates before the expiration date, the option shares will be exercisable for two years following termination of service, unless the Reporting Person is terminated for cause, in which case the options shall terminate immediately."}],"balance_after":50000,"derivative":{"exercise_price":19.93,"expiration_date":"2029-06-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-19-030597","document":"tv523382_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000114420419030597/tv523382_4.xml","form_type":"4"}},{"id":3864420,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-19T21:39:02.000Z","date":"2018-07-17","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are exercisable in four equal quarterly installments of 8,750 each following the date of grant. If the Reporting Person's service to the Issuer terminates before the expiration date, the option shares will be exercisable for two years following termination of service, unless the Reporting Person is terminated for cause, in which case the options shall terminate immediately."}],"balance_after":35000,"derivative":{"exercise_price":14.45,"expiration_date":"2028-07-16","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001250853-18-000103","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000125085318000103/primary_doc.xml","form_type":"4"}},{"id":3989443,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-19T20:29:10.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are exercisable in four equal quarterly installments of 12,500 each following the date of grant. If the Reporting Person's service to the Issuer terminates before the expiration date, the option shares will be exercisable for two years following termination of service unless the Reporting Person is terminated for cause, in which case the options are terminated."}],"balance_after":50000,"derivative":{"exercise_price":16.2,"expiration_date":"2028-03-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001250853-18-000043","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000125085318000043/primary_doc.xml","form_type":"4"}},{"id":4113050,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-03T22:02:17.000Z","date":"2017-12-30","kind":"tax_withholding","acquired":false,"shares":6021,"price":4.14,"value":24926.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":224282,"source":{"system":"sec-edgar","filing":"0001209191-18-001023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919118001023/doc4.xml","form_type":"4"}},{"id":4113049,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-03T22:02:17.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":17258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"17,258 shares vest on 12/29/2018."}],"balance_after":230303,"source":{"system":"sec-edgar","filing":"0001209191-18-001023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919118001023/doc4.xml","form_type":"4"}},{"id":4136712,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-12-11T21:34:52.000Z","date":"2017-12-08","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"6,667 shares vested on each of 12/12/08 and 12/12/09; 6,666 shares vested on 12/12/10."}],"balance_after":0,"derivative":{"exercise_price":2.73,"expiration_date":"2017-12-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-17-065008","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919117065008/doc4.xml","form_type":"4"}},{"id":4136711,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-11T21:34:52.000Z","date":"2017-12-08","kind":"tax_withholding","acquired":false,"shares":12325,"price":4.43,"value":54599.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to pay exercise price."}],"balance_after":213045,"source":{"system":"sec-edgar","filing":"0001209191-17-065008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919117065008/doc4.xml","form_type":"4"}},{"id":4136710,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-11T21:34:52.000Z","date":"2017-12-08","kind":"exercise","acquired":true,"shares":20000,"price":2.73,"value":54600.0,"ownership":{"direct":true},"balance_after":225370,"source":{"system":"sec-edgar","filing":"0001209191-17-065008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919117065008/doc4.xml","form_type":"4"}},{"id":4282482,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-14T20:28:05.000Z","date":"2017-06-12","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"5,000 shares vested and became exercisable on each of 6/18/08, 6/18/09 and 6/18/10."}],"balance_after":0,"derivative":{"exercise_price":4.85,"expiration_date":"2017-06-18","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-039824","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919117039824/doc4.xml","form_type":"4"}},{"id":4282481,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-14T20:28:05.000Z","date":"2017-06-12","kind":"tax_withholding","acquired":false,"shares":13300,"price":5.47,"value":72751.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to pay exercise price."}],"balance_after":205370,"source":{"system":"sec-edgar","filing":"0001209191-17-039824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919117039824/doc4.xml","form_type":"4"}},{"id":4282480,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-14T20:28:05.000Z","date":"2017-06-12","kind":"exercise","acquired":true,"shares":15000,"price":4.85,"value":72750.0,"ownership":{"direct":true},"balance_after":218670,"source":{"system":"sec-edgar","filing":"0001209191-17-039824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919117039824/doc4.xml","form_type":"4"}},{"id":4307254,"issuer":{"id":174671,"kind":"organization","name":"EMISPHERE TECHNOLOGIES INC","symbol":"EMIS"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2017-05-24T16:00:23.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the options subject to this grant shall vest on each of the first three anniversaries of the grant date."}],"balance_after":40000,"derivative":{"exercise_price":0.47,"exercise_date":"2018-05-18","expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-17-014232","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805326/000089924317014232/doc4.xml","form_type":"4"}},{"id":4503582,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T21:35:40.000Z","date":"2016-12-31","kind":"tax_withholding","acquired":false,"shares":9331,"price":5.35,"value":49920.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":203670,"source":{"system":"sec-edgar","filing":"0001209191-17-000952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919117000952/doc4.xml","form_type":"4"}},{"id":4503581,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":36778,"kind":"person","name":"WEISER MICHAEL","position":1,"cik":"0001221449","reported_name":"WEISER MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T21:35:40.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":17204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"17,204 shares shall vest on 12/30/2017."}],"balance_after":213001,"source":{"system":"sec-edgar","filing":"0001209191-17-000952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919117000952/doc4.xml","form_type":"4"}}]}